n−3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases

The American Journal of Clinical Nutrition - Tập 83 Số 6 - Trang 1505S-1519S - 2006
Philip C. Calder1
1From the Institute of Human Nutrition, School of Medicine, University of Southampton, Southampton, United Kingdom

Tóm tắt

Từ khóa


Tài liệu tham khảo

Calder, 2001, Polyunsaturated fatty acids, inflammation and immunity, Lipids, 36, 1007, 10.1007/s11745-001-0812-7

Lewis, 1990, Leukotrienes and other products of the 5-lipoxygenase pathway: biochemistry and relation to pathobiology in human diseases, N Engl J Med, 323, 645, 10.1056/NEJM199009063231006

Tilley, 2001, Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes, J Clin Invest, 108, 15, 10.1172/JCI200113416

Calder, 2004, N-3 fatty acids, inflammation and immunity—relevance to postsurgical and critically ill patients, Lipids, 39, 1147, 10.1007/s11745-004-1342-z

Bagga, 2003, Differential effects of prostaglandin derived from ω-6 and ω-3 polyunsaturated fatty acids on COX-2 expression and IL-6 secretion, Proc Natl Acad Sci U S A, 100, 1751, 10.1073/pnas.0334211100

Levy, 2001, Lipid mediator class switching during acute inflammation: signals in resolution, Nat Immunol, 2, 612, 10.1038/89759

Vachier, 2002, Endogenous anti-inflammatory mediators from arachidonate in human neutrophils, Biochem Biophys Res Commun, 290, 219, 10.1006/bbrc.2001.6155

Gewirtz, 2002, Lipoxin A4 analogs attenuate induction of intestinal epithelial proinflammatory gene expression and reduce the severity of dextran sodium sulfate-induced colitis, J Immunol, 168, 5260, 10.4049/jimmunol.168.10.5260

Serhan, 2003, Reduced inflammation and tissue damage in transgenic rabbits overexpressing 15-lipoxygenase and endogenous anti-inflammatory lipid mediators, J Immunol, 171, 6856, 10.4049/jimmunol.171.12.6856

Peterson, 1998, Eicosapentaenoic and docosahexaenoic acids alter rat spleen leukocyte fatty acid composition and prostaglandin E2 production but have different effects on lymphocyte functions and cell-mediated immunity, Lipids, 33, 171, 10.1007/s11745-998-0193-y

Thies, 2001, Dietary supplementation with γ-linolenic acid or fish oil decreases T lymphocyte proliferation in healthy older humans, J Nutr, 131, 1918, 10.1093/jn/131.7.1918

Yaqoob, 2000, Encapsulated fish oil enriched in α-tocopherol alters plasma phospholipid and mononuclear cell fatty acid compositions but not mononuclear cell functions, Eur J Clin Invest, 30, 260, 10.1046/j.1365-2362.2000.00623.x

Kelley, 1998, Arachidonic acid supplementation enhances synthesis of eicosanoids without suppressing immune functions in young healthy men, Lipids, 33, 125, 10.1007/s11745-998-0187-9

Thies, 2001, Influence of dietary supplementation with long chain n−3 or n–6 polyunsaturated fatty acids on blood inflammatory cell populations and functions and on plasma soluble adhesion molecules in healthy adults, Lipids, 36, 1183, 10.1007/s11745-001-0831-4

Lee, 1985, Effects of dietary enrichment with eicosapentaenoic acid and docosahexaenoic acid on in vitro neutrophil and monocyte leukotriene generation and neutrophil function, N Engl J Med, 312, 1217, 10.1056/NEJM198505093121903

Endres, 1989, The effect of dietary supplementation with n−3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells, N Engl J Med, 320, 265, 10.1056/NEJM198902023200501

Sperling, 1993, Dietary ω-3 polyunsaturated fatty acids inhibit phosphoinositide formation and chemotaxis in neutrophils, J Clin Invest, 91, 651, 10.1172/JCI116245

Gibney, 1993, The effects of short- and long-term supplementation with fish oil on the incorporation of n−3 polyunsaturated fatty acids into cells of the immune system in healthy volunteers, Eur J Clin Nutr, 47, 255

Caughey, 1996, The effect on human tumor necrosis factor α and interleukin 1β production of diets enriched in n−3 fatty acids from vegetable oil or fish oil, Am J Clin Nutr, 63, 116, 10.1093/ajcn/63.1.116

Healy, 2000, The effect of low to moderate amounts of dietary fish oil on neutrophil lipid composition and function, Lipids, 35, 763, 10.1007/s11745-000-0583-1

Meydani, 1991, Oral (n-3) fatty acid supplementation suppresses cytokine production and lymphocyte proliferation: comparison between young and older women, J Nutr, 121, 547, 10.1093/jn/121.4.547

Trebble, 2003, Prostaglandin E2 production and T-cell function after fish-oil supplementation: response to antioxidant co-supplementation, Am J Clin Nutr, 78, 376, 10.1093/ajcn/78.3.376

Von Schacky, 1993, N-3 fatty acids and cysteinyl-leukotriene formation in humans in vitro, ex vivo and in vivo, J Lab Clin Med, 121, 302

Kelley, 1999, Docosahexaenoic acid ingestion inhibits natural killer cell activity and production of inflammatory mediators in young healthy men, Lipids, 34, 317, 10.1007/s11745-999-0369-5

Hawkes, 1991, Separation and quantification of PGE3 following derivatization with panacyl bromide by high pressure liquid chromatography with fluorometric detection, Prostaglandins, 42, 355, 10.1016/0090-6980(91)90084-S

Goldman, 1983, Human neutrophil chemotactic and degranulating activities of leukotriene B5 (LTB5) derived from eicosapentaenoic acid, Biochem Biophys Res Commun, 117, 282, 10.1016/0006-291X(83)91572-3

Lee, 1984, Characterization and biologic properties of 5,12-dihydroxy derivatives of eicosapentaenoic acid, including leukotriene-B5 and the double lipoxygenase product, J Biol Chem, 259, 2383, 10.1016/S0021-9258(17)43363-1

Dooper, 2002, The modulatory effects of prostaglandin-E on cytokine production by human peripheral blood mononuclear cells are independent of the prostaglandin subtype, Immunology, 107, 152, 10.1046/j.1365-2567.2002.01474.x

Miles, 2002, In vitro effects of eicosanoids derived from different 20-carbon fatty acids on production of monocyte-derived cytokines in human whole blood cultures, Cytokine, 20, 215, 10.1006/cyto.2002.2007

Serhan, 2000, Anti-inflammatory lipid signals generated from dietary n−3 fatty acids via cyclooxygenase-2 and transcellular processing: a novel mechanism for NSAID and n−3 PUFA therapeutic actions, J Physiol Pharmacol, 4, 643

Serhan, 2000, Novel functional sets of lipid-derived mediators with antinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing, J Exp Med, 192, 1197, 10.1084/jem.192.8.1197

Serhan, 2002, Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter pro-inflammation signals, J Exp Med, 196, 1025, 10.1084/jem.20020760

Hong, 2003, Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood and glial cells: autocoids in anti-inflammation, J Biol Chem, 278, 14677, 10.1074/jbc.M300218200

Marcheselli, 2003, Novel docosanoids inhibit brain ischemia reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression, J Biol Chem, 278, 43807, 10.1074/jbc.M305841200

Mukherjee, 2004, Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress, Proc Natl Acad Sci U S A, 101, 8491, 10.1073/pnas.0402531101

Serhan, 2004, Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their endogenous aspirin-triggered epimers, Lipids, 39, 1125, 10.1007/s11745-004-1339-7

Serhan, 2005, Novel eicosanoid and docosanoid mediators: resolvins, docosatrienes, and neuroprotrectins, Curr Opin Clin Nutr Metab Care, 8, 115, 10.1097/00075197-200503000-00003

Schmidt, 1989, Cod liver oil inhibits neutrophil and monocyte chemotaxis in healthy males, Atherosclerosis, 77, 53, 10.1016/0021-9150(89)90009-9

Schmidt, 1992, Long term supplementation with n−3 fatty acids. ii. Effect on neutrophil and monocyte chemotaxis, Scand J Clin Lab Invest, 52, 229, 10.3109/00365519209088790

Luostarinen, 1992, Effect of dietary fish oil supplemented with different doses of vitamin, E on neutrophil chemotaxis in healthy volunteers. Nutr Res, 12, 1419

Schmidt, 1991, N-3 fatty acids and leukocyte chemotaxis: effects in hyperlipidemia, and dose-response studies in healthy males, Arterioscler Thromb, 11, 429, 10.1161/01.ATV.11.2.429

Schmidt, 1996, No effect of a very low dose of n-3 fatty acids on monocyte function in healthy humans, Scand J Clin Invest, 56, 87, 10.1080/00365519609088592

De Caterina, 1994, The omega-3 fatty acid docosahexaenoate reduces cytokine-induced expression of proatherogenic and proinflammatory proteins in human endothelial cells, Arterioscler Thromb, 14, 1829, 10.1161/01.ATV.14.11.1829

De Caterina, 1996, Control of endothelial leukocyte adhesion molecules by fatty acids, Lipids, 31, S57, 10.1007/BF02637052

Collie-Duguid, 1996, Inhibitory effect of fish oil n−3 polyunsaturated fatty acids on the expression of endothelial cell adhesion molecules, Biochem Biophys Res Commun., 220, 969, 10.1006/bbrc.1996.0516

Hughes, 1996, (n-3) Polyunsaturated fatty acids modulate the expression of functionally associated molecules on human monocytes in vitro, J Nutr, 126, 603, 10.1093/jn/126.3.603

Miles, 2000, Dietary fish oil reduces intercellular adhesion molecule 1 and scavenger receptor expression on murine macrophages, Atherosclerosis, 152, 43, 10.1016/S0021-9150(99)00446-3

Hughes, 1996, Fish oil supplementation inhibits the expression of major histocompatibility complex class II molecules and adhesion molecules on human monocytes, Am J Clin Nutr, 63, 267, 10.1093/ajcn/63.2.267

Miles, 2001, Influence of age and dietary fish oil on plasma soluble adhesion molecule concentrations, Clin Sci, 100, 91, 10.1042/cs1000091

Varming, 1995, The effect of n−3 fatty acids on neutrophil chemiluminescence, Scand J Clin Lab Invest, 55, 47, 10.3109/00365519509075377

Thompson, 1991, The effect of eicosapentaenoic acid consumption on human neutrophil chemiluminescence, Lipids, 26, 1223, 10.1007/BF02536536

Luostarinen, 1996, Dietary fish oil decreases superoxide generation by human neutrophils: relation to cyclooxygenase pathway and lysosomal enzyme release, Prost Leuk Essent Fatty Acids, 55, 167, 10.1016/S0952-3278(96)90093-9

Fisher, 1990, Dietary n−3 fatty acid supplementation reduces superoxide production and chemiluminescence in monocyte enriched preparation of leukocytes, Am J Clin Nutr, 51, 804, 10.1093/ajcn/51.5.804

Kew, 2003, Lack of effect of foods enriched with plant- or marine-derived n−3 fatty acids on human immune function, Am J Clin Nutr, 77, 1287, 10.1093/ajcn/77.5.1287

Miles, 2004, The influence of different combinations of γ-linolenic acid, stearidonic acid and EPA on immune function in healthy young male subjects, Br J Nutr, 91, 893, 10.1079/BJN20041131

Halvorsen, 1997, The effect of highly purified eicosapentaenoic and docosahexaenoic acids on monocyte phagocytosis in man, Lipids, 32, 935, 10.1007/s11745-997-0120-2

Lo, 1999, Fish oil decreases macrophage tumor necrosis factor gene transcription by altering the NFκB activity, J Surg Res, 82, 216, 10.1006/jsre.1998.5524

Babcock, 2002, Modulation of lipopolysaccharide-stimulated macrophage tumor necrosis factor-α production by ω-3 fatty acid is associated with differential cyclooxygenase-2 protein expression and is independent of interleukin-10, J Surg Res, 107, 135

Novak, 2003, NF-κB inhibition by ω-3 fatty acids modulates LPS-stimulated macrophage TNF-α transcription, Am J Physiol, 284, L84

Zhao, 2004, Eicosapentaenoic acid prevents LPS-induced TNF-α expression by preventing NF-κB activation, J Am Coll Nutr, 23, 71, 10.1080/07315724.2004.10719345

Khalfoun, 1997, Docosahexaenoic and eicosapentaenoic acids inhibit in vitro human endothelial cell production of interleukin-6, Adv Exp Biol Med, 400, 589

Billiar, 1988, Fatty acid uptake and Kupffer Cell function: fish oil alters eicosanoid and monokine production to endotoxin stimulation, Surgery, 104, 343

Renier, 1993, Dietary n−3 polyunsaturated fatty acids prevent the development of atherosclerotic lesions in mice: modulation of macrophage secretory activities, Arterioscler Thomb, 13, 1515, 10.1161/01.ATV.13.10.1515

Yaqoob, 1995, Effects of dietary lipid manipulation upon inflammatory mediator production by murine macrophages, Cell Immunol, 163, 120, 10.1006/cimm.1995.1106

Abbate, 1996, N-3 PUFA supplementation, monocyte PCA expression and interleukin-6 production, Prostaglandins Leukot Essent Fatty Acids, 54, 439, 10.1016/S0952-3278(96)90028-9

Gallai, 1993, Cytokine secretion and eicosanoid production in the peripheral blood mononuclear cells of MS patients undergoing dietary supplementation with n−3 polyunsaturated fatty acids, J Neuroimmunol, 56, 143, 10.1016/0165-5728(94)00140-J

Trebble, 2003, Inhibition of tumour necrosis factor-α and interleukin-6 production by mononuclear cells following dietary fish-oil supplementation in healthy men and response to antioxidant co-supplementation, Br J Nutr, 90, 405, 10.1079/BJN2003892

Mori, 2003, Effect of eicosapentaenoic acid and docosahexaenoic acid on oxidative stress and inflammatory markers in treated-hypertensive type 2 diabetic subjects, Free Radic Biol Med, 35, 772, 10.1016/S0891-5849(03)00407-6

Cooper, 1993, Effect of dietary fish oil supplementation on fever and cytokine production in human volunteers, Clin Nutr, 12, 321, 10.1016/0261-5614(93)90027-2

Wallace, 2003, Comparison of the effects of linseed oil and different doses of fish oil on mononuclear cell function in healthy human subjects, Br J Nutr, 89, 679, 10.1079/BJN2002821

Blok, 1997, Pro- and anti-inflammatory cytokines in healthy volunteers fed various doses of fish oil for 1 year, Eur J Clin Invest, 27, 1003, 10.1046/j.1365-2362.1997.2240775.x

Cannon, 1995, Aging and dietary modulation of elastase and interleukin-2 beta secretion, Am J Physiol, 268, R208

Molvig, 1991, Dietary supplementation with omega 3 polyunsaturated fatty acids decreases mononuclear cell proliferation and interleukin 1 beta content but not monokine secretion in healthy and insulin dependent diabetic individuals, Scand J Immunol, 34, 399, 10.1111/j.1365-3083.1991.tb01563.x

Kew, 2004, Effects of oils rich in eicosapentaenoic and docosahexaenoic acids on immune cell composition and function in healthy humans, Am J Clin Nutr, 79, 674, 10.1093/ajcn/79.4.674

Calder, 2001, N-3 polyunsaturated fatty acids, inflammation and immunity: pouring oil on troubled waters or another fishy tale?, Nutr Res, 21, 309, 10.1016/S0271-5317(00)00287-6

Grimble, 2002, The ability of fish oil to suppress tumor necrosis factor-α production by peripheral blood mononuclear cells in healthy men is associated with polymorphisms in genes that influence tumor necrosis factor α production, Am J Clin Nutr, 76, 454, 10.1093/ajcn/76.2.454

Feldmann, 1999, The role of cytokines in the pathogenesis of rheumatoid arthritis, Rheumatology (Oxford), 38, 3

Dignass, 2004, Review article: the aetiopathogenesis of inflammatory bowel disease—immunology and repair mechanisms, Aliment Pharmacol Ther, 20, 9, 10.1111/j.1365-2036.2004.02047.x

Smolen, 2005, Anti-cytokine therapy in systemic lupus erythematosus, Lupus, 14, 189, 10.1191/0961203305lu2134oa

Donath, 2003, Inflammatory mediators and islet beta-cell failure: a link between type 1 and type 2 diabetes, J Mol Med, 81, 455, 10.1007/s00109-003-0450-y

Caballero, 2004, Endothelial dysfunction, inflammation, and insulin resistance: a focus on subjects at risk for type 2 diabetes, Curr Diab Rep, 4, 237, 10.1007/s11892-004-0074-9

Dinwiddie, 2005, Anti-inflammatory therapy in cystic fibrosis, J Cyst Fibros, 4, 45, 10.1016/j.jcf.2005.05.010

Lemanske, 2002, Inflammation in childhood asthma and other wheezing disorders, Pediatrics, 109, 368, 10.1542/peds.109.SE1.368

King, 1999, A new look at the pathophysiology of asthma, J Natl Med Assoc, 91, 9S

Bochner, 2005, Allergy and asthma, J Allergy Clin Immunol, 115, 953, 10.1016/j.jaci.2005.02.032

Kreuger, 2005, Psoriasis pathophysiology: current concepts of pathogenesis, Ann Rheum Dis, 64, ii30

Rostasy, 2005, Inflammation and neuroaxonal injury in multiple sclerosis and AIDS dementia complex: implications for neuroprotective treatment, Neuropediatrics, 36, 230, 10.1055/s-2005-865864

Klegeris, 2005, Non-steroidal anti-inflammatory drugs (NSAIDs) and other anti-inflammatory agents in the treatment of neurodegenerative disease, Curr Alzheimer Res, 2, 355, 10.2174/1567205054367883

Ross, 1999, Mechanisms of disease—atherosclerosis—an inflammatory disease, N Engl J Med, 340, 115, 10.1056/NEJM199901143400207

Glass, 2001, Atherosclerosis: the road ahead, Cell, 104, 503, 10.1016/S0092-8674(01)00238-0

Plutzky, 1999, Atherosclerotic plaque rupture: emerging insights and opportunities, Am J Cardiol, 84, 5J, 10.1016/S0002-9149(99)00352-5

Wellen, 2003, Obesity-induced inflammatory changes in adipose tissue, J Clin Invest, 112, 1785, 10.1172/JCI20514

Bone, 1997, Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis, Chest, 101, 1644, 10.1378/chest.101.6.1644

Bhatia, 2004, Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome, J Pathol, 202, 145, 10.1002/path.1491

Argiles, 2005, The pivotal role of cytokines in muscle wasting during cancer, Int J Biochem Cell Biol, 37, 2036, 10.1016/j.biocel.2005.03.014

Sano, 1992, In vivo cyclooxygenase expression in synovial tissues of patients with rheumatoid arthritis and osteoarthritis and rats with adjuvant and streptococcal cell wall arthritis, J Clin Invest, 89, 97, 10.1172/JCI115591

Sperling, 1995, Eicosanoids in rheumatoid arthritis, Rheum Dis Clin N Am, 21, 741, 10.1016/S0889-857X(21)00465-8

Faull, 1995, Adhesion molecules in health and disease, Aust N Z J Med, 25, 720, 10.1111/j.1445-5994.1995.tb02861.x

Leslie, 1985, Dietary fish oil modulates macrophage fatty acids and decreases arthritis susceptibility in mice, J Exp Med, 162, 1336, 10.1084/jem.162.4.1336

Volker, 2000, The eicosapentaenoic to docosahexaenoic acid ratio of diets affects the pathogenesis of arthritis in Lew/SSN rats, J Nutr, 130, 559, 10.1093/jn/130.3.559

Kremer, 1985, Effects of manipulation of dietary fatty acids on manifestations of rheumatoid arthritis, Lancet, 1, 184, 10.1016/S0140-6736(85)92024-0

Kremer, 1987, Fish-oil supplementation in active rheumatoid arthritis, Ann Intern Med, 106, 497, 10.7326/0003-4819-106-4-497

Cleland, 1988, Clinical and biochemical effects of dietary fish oil supplements in rheumatoid arthritis, J Rheumatol, 15, 1471

van der Tempel, 1990, Effects of fish oil supplementation in rheumatoid arthritis, Ann Rhem Dis, 49, 76, 10.1136/ard.49.2.76

Tullekan, 1990, status during dietary fish oil supplementation in rheumatoid arthritis, Arthritis Rheum, 33, 1416, 10.1002/art.1780330914

Kremer, 1990, Dietary fish oil and olive oil supplementation in patients with rheumatoid arthritis, Arthritis Rheum, 33, 810, 10.1002/art.1780330607

Esperson, 1992, Decreased interleukin-1 beta levels in plasma from rheumatoid arthritis patients after dietary supplementation with n−3 polyunsaturated fatty acids, Clin Rheumatol, 11, 393, 10.1007/BF02207200

Sperling, 1987, Effects of dietary supplementation with marine fish oil on leukocyte lipid mediator generation and function in rheumatoid arthritis, Arthritis Rheum, 30, 988, 10.1002/art.1780300905

Skoldstam, 1992, Effect of six months of fish oil supplementation in stable rheumatoid arthritis: a double blind, controlled study, Scand J Rheumatol, 21, 178, 10.3109/03009749209099218

Nielsen, 1992, The effects of dietary supplementation with n−3 polyunsaturated fatty acids in patients with rheumatoid arthritis: a randomized, double blind trial, Eur J Clin Invest, 22, 687, 10.1111/j.1365-2362.1992.tb01431.x

Kjeldsen-Kragh, 1992, Dietary omega-3 fatty acid supplementation and naproxen treatment in patients with rheumatoid arthritis, J Rheumatol, 19, 1531

Lau, 1993, Effects of fish oil supplementation on non-steroidal anti-inflammatory drug requirement in patients with mild rheumatoid arthritis, Br J Rheumatol, 32, 982, 10.1093/rheumatology/32.11.982

Geusens, 1994, Long-term effect of omega-3 fatty acid supplementation in active rheumatoid arthritis, Arthritis Rheum, 37, 824, 10.1002/art.1780370608

Kremer, 1995, Effects of high-dose fish oil on rheumatoid arthritis after stopping nonsteroidal antiinflammatory drugs: clinical and immune correlates, Arthritis Rheum, 38, 1107, 10.1002/art.1780380813

Volker, 2000, Efficacy of fish oil concentrate in the treatment of rheumatoid arthritis, J Rheumatol, 27, 2343

Adam, 2003, Anti-inflammatory effects of a low arachidonic acid diet and fish oil in patients with rheumatoid arthritis, Rheumatol Int, 23, 27, 10.1007/s00296-002-0234-7

Remans, 2004, Nutrient supplementation with polyunsaturated fatty acids and micronutrients in rheumatoid arthritis: clinical and biochemical effects, Eur J Clin Nutr, 58, 839, 10.1038/sj.ejcn.1601883

Berbert, 2005, Supplementation of fish oil and olive oil in patients with rheumatoid arthritis, Nutrition, 21, 131, 10.1016/j.nut.2004.03.023

Fortin, 1995, Validation of a meta-analysis: the effects of fish oil in rheumatoid arthritis, J Clin Epidemiol, 48, 1379, 10.1016/0895-4356(95)00028-3

MacLean, 2004

James, 1997, Dietary n−3 fatty acids and therapy for rheumatoid arthritis, Semin Arthritis Rheum, 27, 85, 10.1016/S0049-0172(97)80009-1

Geusens, 1998, N–3 fatty acids in the treatment of rheumatoid arthritis, 111

Kremer, 2000, N–3 fatty acid supplements in rheumatoid arthritis, Am J Clin Nutr, 71, 349S, 10.1093/ajcn/71.1.349S

Volker, 1996, Dietary n−3 fatty acid supplementation in rheumatoid arthritis—mechanisms, clinical outcomes, controversies, and future directions, J Clin Biochem Nutr, 20, 83, 10.3164/jcbn.20.83

Calder, 2001, The scientific basis for fish oil supplementation in rheumatoid arthritis, 175

Calder, 2001, Polyunsaturated fatty acids and rheumatoid arthritis, Curr Opin Clin Nutr Metab Care, 4, 115, 10.1097/00075197-200103000-00006

Cleland, 2000, Fish oil and rheumatoid arthritis: antiinflammatory and collateral health benefits, J Rheumatol, 27, 2305

Sharon, 1984, Enhanced synthesis of leukotriene B4 by colonic mucosa in inflammatory bowel disease, Gastroenterology, 86, 453, 10.1016/S0016-5085(84)80015-3

Shoda, 1996, Epidemiologic analysis of Crohn disease in Japan: increased dietary intake of n–6 polyunsaturated fatty acids and animal protein relates to the increased incidence of Crohn disease in Japan, Am J Clin Nutr, 63, 741, 10.1093/ajcn/63.5.741

Wallace, 1989, Anti-inflammatory effects of a fish oil diet in a rat model of chronic colitis, Gastroenterology, 96, A535

Vilaseca, 1990, Dietary fish oil reduces progression of chronic inflammatory lesions in a rat model of granulomatous colitis, Gut, 31, 539, 10.1136/gut.31.5.539

Lorenz, 1989, Supplementation with n−3 fatty acids from fish oil in chronic inflammatory bowel disease—a randomized, placebo-controlled, double-blind cross-over trial, J Intern Med Suppl, 731, 225, 10.1111/j.1365-2796.1989.tb01461.x

Hillier, 1991, Incorporation of fatty acids from fish oil and olive oil into colonic mucosal lipids and effects upon eicosanoid synthesis in inflammatory bowel disease, Gut, 32, 1151, 10.1136/gut.32.10.1151

Hawthorne, 1992, Treatment of ulcerative colitis with fish oil supplementation: a prospective 12 month randomised controlled trial, Gut, 33, 922, 10.1136/gut.33.7.922

McCall, 1989, Therapeutic potential of fish oil in the treatment of ulcerative colitis, Aliment Pharmacol Ther, 3, 415, 10.1111/j.1365-2036.1989.tb00232.x

Shimizu, 2003, Effects of highly purified eicosapentaenoic acid on erythrocyte fatty acid composition and leukocyte and colonic mucosa leukotriene B4 production in children with ulcerative colitis, Pediatr Gastroenterol Nutr, 37, 581, 10.1097/00005176-200311000-00015

Stenson, 1992, Dietary supplementation with fish oil in ulcerative colitis, Ann Intern Med, 116, 609, 10.7326/0003-4819-116-8-609

Trebble, 2004, Fish oil and antioxidants alter the composition and function of circulating mononuclear cells in Crohns disease, Am J Clin Nutr, 80, 1137, 10.1093/ajcn/80.5.1137

Salomon, 1990, Treatment of ulcerative colitis with fish oil n−3-omega-fatty acid: an open trial, J Clin Gastroenterol, 12, 157, 10.1097/00004836-199004000-00009

Aslan, 1992, Fish oil fatty acid supplementation in active ulcerative colitis: a double-blind, placebo-controlled, crossover study, Am J Gastroenterol, 87, 432

Greenfield, 1993, A randomized controlled study of evening primrose oil and fish oil in ulcerative colitis, Aliment Pharmacol Ther, 7, 159, 10.1111/j.1365-2036.1993.tb00085.x

Belluzzi, 1996, Effect of an enteric-coated fish-oil preparation on relapses in Crohns disease, N Engl J Med, 334, 1557, 10.1056/NEJM199606133342401

Loeschke, 1996, n−3 fatty acids only delay early relapse of ulcerative colitis in remission, Dig Dis Sci, 41, 2087, 10.1007/BF02093614

Lorenz-Meyer, 1996, Omega-3 fatty acids and low carbohydrate diet for maintenance of remission in Crohns disease: a randomized controlled multicenter trial, Scand J Gastroenterol, 31, 778, 10.3109/00365529609010352

Mantzaris, 1996, A prospective, randomized, placebo-controlled study of fish oil in ulcerative colitis, Hell J Gastroenterol, 9, 138

Almallah, 1998, Distal procto-colitis, natural cytotoxicity, and essential fatty acids, Am J Gastroenterol, 93, 804, 10.1111/j.1572-0241.1998.229_a.x

Almallah, 2000, Distal proctocolitis and n−3 polyunsaturated fatty acids (n−3 PUFAs): the mucosal effect in situ, J Clin Immunol, 20, 68, 10.1023/A:1006698728816

Varghese, 2000, Clinical response of ulcerative colitis with dietary omega-3 fatty acids: a double-blind randomized study, Br J Surg, 87, 73

Trebble, 2005, High dose fish oil and antioxidants in Crohns disease and the response of bone turnover: a randomised controlled trial, Br J Nutr, 94, 253, 10.1079/BJN20051466

Rodgers, 1998, N-3 fatty acids in the treatment of ulcerative colitis, 103

Belluzzi, 2002, N–3 fatty acids for the treatment of inflammatory bowel diseases, Proc Nutr Soc, 61, 391, 10.1079/PNS2002171

Belluzzi, 2000, Polyunsaturated fatty acids and inflammatory bowel disease, Am J Clin Nutr, 71, 339S, 10.1093/ajcn/71.1.339S

Henderson, 1994, Role of leukotrienes in asthma, Ann Allergy, 72, 272

Miles, 2003, In vitro effects of eicosanoids derived from different 20-carbon fatty acids on T helper type 1 and T helper type 2 cytokine production in human whole-blood cultures, Clin Exp Allergy, 33, 624, 10.1046/j.1365-2222.2003.01637.x

Roper, 1994, Prostaglandin E2 regulation of the immune response, Adv Prostaglandin Thromboxane Leukot Res, 22, 101

Hodge, 1994, Increased consumption of polyunsaturated oils may be a cause of increased prevalence of childhood asthma, Aust N Z J Med, 24, 727, 10.1111/j.1445-5994.1994.tb01793.x

Black, 1997, Dietary fat and asthma: is there a connection?, Eur Respir J, 10, 6, 10.1183/09031936.97.10010006

Hodge, 1996, Consumption of oily fish and childhood asthma risk, Med J Aust, 164, 137, 10.5694/j.1326-5377.1996.tb122010.x

Dunder, 2001, Diet, serum fatty acids, and atopic diseases in childhood, Allergy, 56, 425, 10.1034/j.1398-9995.2001.056005425.x

Dunstan, 2003, Maternal fish oil supplementation in pregnancy reduces interleukin-13 levels in cord blood of infants at high risk of atopy, Clin Exp Allergy, 33, 442, 10.1046/j.1365-2222.2003.01590.x

Dunstan, 2003, Fish oil supplementation in pregnancy modifies neonatal allergen-specific immune responses and clinical outcomes in infants at high risk of atopy: a randomized, controlled trial, J Allergy Clin Immunol, 112, 1178, 10.1016/j.jaci.2003.09.009

Payan, 1986, Alterations in human leukocyte function induced by ingestion of eicosapentaenoic acid, J Clin Immunol, 6, 402, 10.1007/BF00915380

Arm, 1988, Effect of dietary supplementation with fish oil lipids on mild asthma, Thorax, 43, 84, 10.1136/thx.43.2.84

Kirsch, 1988, Effect of eicosapentaenoic acid in asthma, Clin Allergy, 18, 177, 10.1111/j.1365-2222.1988.tb02857.x

Schachter, 2004

Arm, 1989, The effects of dietary supplementation with fish oil lipids on the airways response to inhaled allergen in bronchial asthma, Am Rev Respir Dis, 139, 1395, 10.1164/ajrccm/139.6.1395

Stenius-Aarniala, 1989, Evening primose oil and fish oil are ineffective as supplementary treatment of bronchial asthma, Ann Allergy, 62, 534

Dry, 1991, Effect of a fish oil diet on asthma: results of a 1-year double-blind study, Int Arch Allergy Appl Immunol, 95, 156, 10.1159/000235421

McDonald, 1990, Effect of fish oil derived omega-3 fatty acid supplements on asthma control, Aust N Z J Med, 20, 526

Thien, 1993, Dietary fish oil effects on seasonal hay fever and asthma in pollen-sensitive subjects, Am Rev Respir Dis, 147, 1138, 10.1164/ajrccm/147.5.1138

Broughton, 1997, Reduced asthma symptoms with n−3 fatty acid ingestion are related to 5-series leukotriene production, Am J Clin Nutr, 65, 1011, 10.1093/ajcn/65.4.1011

Hodge, 1998, Effect of dietary intake of omega-3 and omega-6 fatty acids on severity of asthma in children, Eur Respir J, 11, 361, 10.1183/09031936.98.11020361

Nagakura, 2000, Dietary supplementation with fish oil rich in omega-3 polyunsaturated fatty acids in children with bronchial asthma, Eur Respir J, 16, 861, 10.1183/09031936.00.16586100

Thien, 2002, Dietary marine fatty acids (fish oil) for asthma in adults and children, Cochrane Database Syst Rev, 2, CD001283

Calder, 2003, N–3 Polyunsaturated fatty acids and inflammation: from molecular biology to the clinic, Lipids, 38, 342, 10.1007/s11745-003-1068-y

Calder, 2005, Polyunsaturated fatty acids and inflammation, Biochem Soc Trans, 33, 423, 10.1042/BST0330423

Yaqoob, 2003, Fatty acids as gatekeepers of immune cell regulation, Trends Immunol, 24, 639, 10.1016/j.it.2003.10.002